Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Alessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Cancer Immunology Research (2017) Vol. 5, Iss. 7, pp. 604-616
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 838
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 183
Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
Ben Wylie, Christophe Macri, Justine D. Mintern, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 521-521
Open Access | Times Cited: 124
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
Eleonora Aricò, Luciano Castiello, Imerio Capone, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1943-1943
Open Access | Times Cited: 105
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
Sara Santagata, Maria Napolitano, Crescenzo D’Alterio, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 77110-77120
Open Access | Times Cited: 75
Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints
Diana Saleiro, Leonidas C. Platanias
Seminars in Immunology (2019) Vol. 43, pp. 101299-101299
Open Access | Times Cited: 55
Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Jong Chul Park, Hari N. Krishnakumar, Srinivas Vinod Saladi
Current Oncology (2022) Vol. 29, Iss. 6, pp. 4185-4198
Open Access | Times Cited: 29
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Sihui Yu, Hongyang Xiao, Li Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188946-188946
Closed Access | Times Cited: 19
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis
Maria Luisa Dupuis, Fabrizio Conti, Angela Maselli, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 52
Epigenetics of Dendritic Cells in Tumor Immunology
Gerard Godoy‐Tena, Esteban Ballestar
Cancers (2022) Vol. 14, Iss. 5, pp. 1179-1179
Open Access | Times Cited: 20
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
Mahsa Ghorbaninejad, Maliheh Khademi-Shirvan, Samaneh Hosseini, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic
Xiaoyong Fu, Carmine De Angelis, Rachel Schiff
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 25
Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
Stefan Förster, Ramin Radpour
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 23
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Ken Maes, Anna Mondino, Juan José Lasarte, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression
Elena Di Nisio, Valerio Licursi, Cecilia Mannironi, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 6, pp. 822-832
Open Access | Times Cited: 5
Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design
Yichao Lu, Jian You
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114457-114457
Open Access | Times Cited: 5
Genome-wide selective sweep analysis of the high-altitude adaptability of yaks by using the copy number variant
E Guangxin, Bai‐Gao Yang, Yanbin Zhu, et al.
3 Biotech (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 13
Epigenetic modulations of immune cells: from normal development to tumor progression
Yuanchun Xu, Zongsheng He, Jing Du, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 16, pp. 5120-5144
Open Access | Times Cited: 4
Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma
Zhenran Liu, Yue Huang, Pin Zhang, et al.
Aging (2024)
Open Access | Times Cited: 1
Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma
Jiayi Zhang, Xinzhan Shi, Mengqi Wang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
Xiaotian He, Dechang Zhao, Xuewen Zhang, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 808-808
Open Access | Times Cited: 3
Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity
Yichao Lu, Xu Liu, Jian You
Nano Today (2023) Vol. 54, pp. 102129-102129
Closed Access | Times Cited: 3
Unraveling the Complex Interconnection between Specific Inflammatory Signaling Pathways and Mechanisms Involved in HIV-Associated Colorectal Oncogenesis
Botle Precious Damane, Thanyani Victor Mulaudzi, Sayed Shakeel Kader, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 748-748
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top